| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199308263290905 |
| P698 | PubMed publication ID | 8341336 |
| P2093 | author name string | Cooper JA | |
| Meade TW | |||
| Peart WS | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 616-619 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Plasma renin activity and ischemic heart disease | |
| P478 | volume | 329 |
| Q38617536 | Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study |
| Q38297868 | Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action? |
| Q34236623 | Angiotensin-converting enzyme inhibitors |
| Q86009430 | Antihypertensive drugs and coronary artery disease : evidence from controlled trials |
| Q48697505 | Association of plasma renin activity and echocardiographic left ventricular hypertrophy with frequency of new coronary events and new atherothrombotic brain infarction in older persons with systemic hypertension |
| Q43725606 | Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. |
| Q34191507 | Clinical Evidence: Emerging approaches in preventing cardiovascular disease. |
| Q42543951 | Decoupled syndecan 1 mRNA and protein expression is differentially regulated by angiotensin II in macrophages |
| Q33743183 | Dietary salt reduction in hypertension--what is the evidence and why is it still controversial? |
| Q41894719 | Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies |
| Q34337227 | Effect of lower sodium intake on health: systematic review and meta-analyses |
| Q71090516 | Effects of dietary sodium on blood pressure in IDDM patients with nephropathy |
| Q33633505 | Evidence based cardiology: emerging approaches in preventing cardiovascular disease |
| Q40587863 | Guidelines for the treatment of hypertension: a critical review |
| Q46617358 | High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations |
| Q61948435 | Insertion/deletion polymorphism in the angiotensin-l-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy |
| Q36835050 | Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view |
| Q41284806 | Is there a link between the circulating renin-angiotensin system and coronary disease? A sceptical view |
| Q37893014 | New roles for renin and prorenin in heart failure and cardiorenal crosstalk |
| Q37258821 | Now that we have a direct renin inhibitor, what should we do with it? |
| Q72193005 | Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells |
| Q34475438 | Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort |
| Q37480881 | Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure |
| Q73295825 | Potential Antithrombotic and Fibrinolytic Properties of the Angiotensin Converting Enzyme Inhibitors |
| Q40548164 | Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials |
| Q40952722 | Renin inhibition |
| Q36815446 | Renin: friend or foe? |
| Q33614275 | Role of ACE inhibitors in hypertension with left ventricular hypertrophy |
| Q33614270 | Role of ACE inhibitors in uncomplicated essential hypertension |
| Q37019887 | The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction |
Search more.